{"id":"https://openalex.org/W4390788657","doi":"https://doi.org/10.1016/j.rcsop.2024.100406","title":"Prescription drug spending by payer: Implications for managed care","display_name":"Prescription drug spending by payer: Implications for managed care","publication_year":2024,"publication_date":"2024-01-12","ids":{"openalex":"https://openalex.org/W4390788657","doi":"https://doi.org/10.1016/j.rcsop.2024.100406","pmid":"https://pubmed.ncbi.nlm.nih.gov/38312738","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10835280"},"language":"en","primary_location":{"id":"doi:10.1016/j.rcsop.2024.100406","doi":"https://doi.org/10.1016/j.rcsop.2024.100406","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2024.100406","pdf_url":null,"source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.rcsop.2024.100406","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040387339","display_name":"Yousef Chavehpour","orcid":"https://orcid.org/0000-0002-4962-6990","observed_orcids":["https://orcid.org/0000-0002-4962-6990"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yousef Chavehpour","raw_affiliation_strings":["Department of Health Policy and Administration, Pennsylvania State University (YC, JES), State College, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Policy and Administration, Pennsylvania State University (YC, JES), State College, PA, USA","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015605411","display_name":"Rajesh Balkrishnan","orcid":"https://orcid.org/0000-0001-9363-9257","observed_orcids":["https://orcid.org/0000-0001-9363-9257"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajesh Balkrishnan","raw_affiliation_strings":["School of Medicine, University of Virginia (RB), Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Virginia (RB), Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044279206","display_name":"Joel E. Segel","orcid":"https://orcid.org/0000-0001-8937-0531","observed_orcids":["https://orcid.org/0000-0001-8937-0531"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joel E. Segel","raw_affiliation_strings":["Penn State Cancer Institute, Pennsylvania State University (JES), Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Cancer Institute, Pennsylvania State University (JES), Hershey, PA, USA","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I4405268258"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044279206"],"corresponding_institution_ids":["https://openalex.org/I130769515","https://openalex.org/I4405268258"],"apc_list":{"value":1800,"currency":"USD","value_usd":1800},"apc_paid":{"value":1800,"currency":"USD","value_usd":1800},"fwci":0.3539,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63855695,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"13","issue":null,"first_page":"100406","last_page":"100406"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.06729999929666519,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prescription-drug-spending","display_name":"prescription drug spending","score":0.9959999918937683},{"id":"https://openalex.org/keywords/brand-name-drugs","display_name":"brand-name drugs","score":0.6859999895095825},{"id":"https://openalex.org/keywords/top-selling-drugs","display_name":"top-selling drugs","score":0.6600000262260437},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.6489999890327454},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.9990000128746033},{"id":"https://openalex.org/keywords/private-insurance","display_name":"private insurance","score":0.8450000286102295},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.9539999961853027},{"id":"https://openalex.org/keywords/managed-care","display_name":"managed care","score":0.7559999823570251},{"id":"https://openalex.org/keywords/prescription-drug-costs","display_name":"prescription drug costs","score":0.5389999747276306},{"id":"https://openalex.org/keywords/prescription-volume","display_name":"prescription volume","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.9210675954818726},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.6580120325088501},{"id":"https://openalex.org/C101864126","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Prescription costs","level":4,"score":0.6149401664733887},{"id":"https://openalex.org/C2776291444","wikidata":"https://www.wikidata.org/wiki/Q6806635","display_name":"Medicare Part D","level":4,"score":0.6103094220161438},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.6010997295379639},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5658189058303833},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47896984219551086},{"id":"https://openalex.org/C2780777579","wikidata":"https://www.wikidata.org/wiki/Q6806347","display_name":"Medical Expenditure Panel Survey","level":4,"score":0.44942378997802734},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.40272560715675354},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3930705487728119},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3503601849079132},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.2537621855735779},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2252664566040039},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.07921093702316284},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0703032910823822}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.rcsop.2024.100406","doi":"https://doi.org/10.1016/j.rcsop.2024.100406","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2024.100406","pdf_url":null,"source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10835280","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10835280","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10835280/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Explor Res Clin Soc Pharm","raw_type":"Text"},{"id":"pmid:38312738","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38312738","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory research in clinical and social pharmacy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ef0b0e738f79421895486a906e7c09b5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ef0b0e738f79421895486a906e7c09b5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy, Vol 13, Iss , Pp 100406- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.rcsop.2024.100406","doi":"https://doi.org/10.1016/j.rcsop.2024.100406","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2024.100406","pdf_url":null,"source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W2513403311","https://openalex.org/W2795346235","https://openalex.org/W2907948509","https://openalex.org/W2917183449","https://openalex.org/W2917469484","https://openalex.org/W2922257886","https://openalex.org/W2947611766","https://openalex.org/W2999445018","https://openalex.org/W3011937534","https://openalex.org/W3091778782","https://openalex.org/W3111066313","https://openalex.org/W4310894725","https://openalex.org/W4311453080","https://openalex.org/W4315928508","https://openalex.org/W6849109836"],"related_works":["https://openalex.org/W4319655654","https://openalex.org/W2695792294","https://openalex.org/W2982219616","https://openalex.org/W2160862999","https://openalex.org/W2116891129","https://openalex.org/W4366171889","https://openalex.org/W7112867839","https://openalex.org/W4243529505","https://openalex.org/W1986248354","https://openalex.org/W7113343600"],"abstract_inverted_index":{"Background:":[0],"Brand-name":[1],"prescription":[2,9,54,70,81,107,119,133,150,195,199,207,216],"drugs":[3,37,55,108,120,196,224],"are":[4],"an":[5],"important":[6],"driver":[7],"of":[8,52,68,86,102,126,131,143,167,190],"drug":[10,71,134,200,217],"spending,":[11,72,74],"but":[12],"different":[13,21],"payers":[14,89,228],"may":[15,225,235],"bear":[16],"these":[17],"costs":[18],"differentially":[19,226],"necessitating":[20],"policy":[22],"goals":[23],"for":[24,84,100,122,154,158,176,181,239],"each":[25,85,101,214],"payer.":[26],"But":[27],"little":[28],"is":[29],"known":[30],"about":[31],"how":[32,220,232],"the":[33,39,48,87,103,140,163,187,191],"top":[34,53,104,192,240],"10":[35,105,118,193],"selling":[36,106,194,241],"in":[38,162,205],"U.S.":[40,198],"impact":[41,189,227],"spending":[42,50,125],"across":[43],"payers.":[44],"Objective:":[45],"To":[46],"estimate":[47],"differential":[49],"burden":[51,218],"on":[56,197],"Medicaid,":[57,91],"Medicare,":[58,92],"commercial":[59],"coverage,":[60],"and":[61,77,83,95,129],"out-of-pocket":[62],"(OOP)":[63],"spending.":[64,135,144,201],"Methods:":[65],"The":[66,145,184,202],"percentage":[67],"total":[69,73,75],"prescriptions,":[76],"average":[78,123,146,164],"cost":[79,148,208],"per":[80,149,206],"overall":[82],"following":[88],"-":[90,97],"private":[93],"insurance,":[94],"OOP":[96],"was":[98,170],"calculated":[99],"using":[109],"2017-2019":[110],"Medical":[111],"Expenditure":[112],"Panel":[113],"Survey":[114],"data.":[115],"Results:":[116],"These":[117],"accounted":[121],"annual":[124,147,165],"$83.4":[127],"billion":[128],"19.0%":[130],"all":[132],"Medicare":[136],"tended":[137],"to":[138,156,178,213],"contribute":[139],"highest":[141],"fraction":[142],"ranged":[151],"from":[152,173],"$500":[153],"Advair":[155],"$7400":[157],"Tecfidera.":[159],"Significant":[160],"variation":[161,204],"number":[166],"prescriptions":[168],"filled":[169],"observed,":[171],"ranging":[172],"1.4":[174],"million":[175,180],"Tecfidera":[177],"13.6":[179],"Lantus.":[182],"Conclusions:":[183],"findings":[185],"highlight":[186],"significant":[188],"wide":[203],"as":[209,211,229,231],"well":[210,230],"contribution":[212],"payer's":[215],"emphasizes":[219],"policies":[221,234],"targeting":[222],"top-selling":[223],"payer-specific":[233],"differ":[236],"substantially":[237],"even":[238],"drugs.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-01-13T00:00:00"}